Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ruhrmann

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
Schizophrenia Bulletin|June 27, 2008
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal stateFrauke Schultze-Lutter, Stephan Ruhrmann, Julia Berning, et al.
Archives of Women'S Mental Health|September 6, 2019
Sex differences in symptomatology of psychosis-risk patients and in prediction of psychosisMarlene Rosen, Theresa Katharina Haidl, Stephan Ruhrmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 27, 2014
Prediction and prevention of psychosis: current progress and future tasksStephan Ruhrmann, Frauke Schultze-Lutter, Stefanie J Schmidt, et al.
Schizophrenia Bulletin|March 11, 2014
A stratified model for psychosis prediction in clinical practiceChantal Michel, Stephan Ruhrmann, Benno G Schimmelmann, et al.
Comprehensive Psychiatry|August 21, 2007
The initial prodrome of schizophrenia: different duration, different underlying deficits?Frauke Schultze-Lutter, Stephan Ruhrmann, Carolin Hoyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 17, 2016
Restricted attention to social cues in schizophrenia patientsAlexandra Nikolaides, Susanne Miess, Isabella Auvera, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2017
Course of clinical high-risk states for psychosis beyond conversionChantal Michel, Stephan Ruhrmann, Benno G Schimmelmann, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2007
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptomsStephan Ruhrmann, Werner Kissling, Otto-Michael Lesch, et al.
Psychopathology|November 7, 2013
Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinationsFrauke Schultze-Lutter, Fritz Renner, Julia Paruch, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 24, 2012
Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophreniaRalf Tepest, Christopher J Schwarzbach, Barbara Krug, et al.
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
Schizophrenia Bulletin|June 27, 2008
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal stateFrauke Schultze-Lutter, Stephan Ruhrmann, Julia Berning, et al.
Archives of Women'S Mental Health|September 6, 2019
Sex differences in symptomatology of psychosis-risk patients and in prediction of psychosisMarlene Rosen, Theresa Katharina Haidl, Stephan Ruhrmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 27, 2014
Prediction and prevention of psychosis: current progress and future tasksStephan Ruhrmann, Frauke Schultze-Lutter, Stefanie J Schmidt, et al.
Schizophrenia Bulletin|March 11, 2014
A stratified model for psychosis prediction in clinical practiceChantal Michel, Stephan Ruhrmann, Benno G Schimmelmann, et al.
Comprehensive Psychiatry|August 21, 2007
The initial prodrome of schizophrenia: different duration, different underlying deficits?Frauke Schultze-Lutter, Stephan Ruhrmann, Carolin Hoyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 17, 2016
Restricted attention to social cues in schizophrenia patientsAlexandra Nikolaides, Susanne Miess, Isabella Auvera, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 6, 2017
Course of clinical high-risk states for psychosis beyond conversionChantal Michel, Stephan Ruhrmann, Benno G Schimmelmann, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2007
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptomsStephan Ruhrmann, Werner Kissling, Otto-Michael Lesch, et al.
Psychopathology|November 7, 2013
Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinationsFrauke Schultze-Lutter, Fritz Renner, Julia Paruch, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 24, 2012
Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophreniaRalf Tepest, Christopher J Schwarzbach, Barbara Krug, et al.
Pageof 18